Dienogest 2 Mg Pharmc 2 mg Tablet
PDF Leaflet Revision Date: May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of endometriosis.
Dosage (summary)
1 tablet daily, starting on day 1 of menstrual cycle, without breaks.
Special Populations
- Diabetes mellitus
- History of depression
- Adolescents
Pregnancy & Breastfeeding
Not recommended during pregnancy or lactation.
Key Drug Interactions
- CYP3A4 inducers (e.g., rifampicin)
- CYP3A4 inhibitors (e.g., ketoconazole)
- Grapefruit juice
Contraindications
- Hypersensitivity to dienogest
- Known or suspected pregnancy
- Lactation
- History of venous thromboembolism
- Cardiovascular diseases
- Severe hepatic disease
- Sex hormone-dependent malignancies
- Undiagnosed vaginal bleeding
Common side effects
- Headache
- Breast discomfort
- Depressed mood
- Acne
Counselling Points
- Take at the same time daily
- Report any severe abdominal pain
- Use non-hormonal contraception if needed
Serious warnings
- Increased risk of thromboembolism
- Changes in bleeding pattern
- Potential for decreased bone mineral density
Important Disclaimer
The Dienogest 2 Mg Pharmc 2 mg Tablet professional information leaflet below is the property of Pharmacorp and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
